Company Overview - Molina Healthcare, Inc. is a leading provider of managed healthcare services focused on government-sponsored programs such as Medicaid and Medicare [6] - The company serves low-income families, individuals, and seniors eligible for Medicaid and Medicare in 18 U.S. states, with approximately 5.2 million members as of December 31, 2021 [7] - Revenue for the trailing twelve months (TTM) is $54.07 billion, with a net income of $883 million and a market capitalization of $7.50 billion [5] Recent Developments - Cobalt Capital Management disclosed a new position in Molina Healthcare, acquiring 115,000 shares valued at approximately $22.01 million, which represents 10.11% of the fund's reportable assets [2][3] - As of November 13, 2025, Molina Healthcare's stock price was $138.48, reflecting a decline of 55.23% over the past year, underperforming the S&P 500 by 69.17 percentage points [4] Investment Insights - Cobalt Capital's significant investment suggests a belief that the market has misjudged the company's potential, indicating a gap between the stock's decline and Molina's cash-generating capabilities [10] - The company's revenue model relies on government contracts that pay a fixed amount per member, making financial performance dependent on effective management of medical costs [11] - Recent challenges in rate negotiations and rising medical costs have negatively impacted the stock price, but the underlying business retains advantages that could support future growth [12]

Core Viewpoint - Molina Healthcare is facing significant operational and financial challenges, with declining Medicaid enrollment and increasing costs impacting profitability and outlook [2][3][6]. Company Overview - Molina Healthcare provides managed healthcare services primarily to low-income families and individuals through Medicare and Medicaid programs [1]. Financial Performance - The company has missed earnings estimates in three of the last four quarters, with a notable miss of -53.65% in Q3, resulting in a trailing four-quarter average earnings miss of -15.8% [6]. - Analysts have revised fourth-quarter earnings estimates down by -87.28% over the past 60 days, with the current Zacks Consensus EPS Estimate at 43 cents, reflecting a negative growth of -91.5% year-over-year [7][8]. Operational Challenges - Medicaid membership has declined by 5.2% in the first nine months of 2025, indicating difficulties in enrollment growth [2]. - Operating expenses have consistently increased, leading to pressure on margins and a worsening medical care ratio [3]. Industry Context - Molina Healthcare is ranked as a Zacks Rank 5 (Strong Sell) and is part of the bottom 16% of the Zacks Medical – HMOs industry group, which is expected to underperform the market in the next 3 to 6 months [4]. - The stock has been underperforming, hitting a 52-week low last month, and is considered a compelling short opportunity [5]. Technical Analysis - The stock is in a sustained downtrend, trading below both the 50-day and 200-day moving averages, indicating bearish sentiment [9][12]. - A "death cross" has occurred, suggesting that significant upward movement would be required to consider long positions [12]. Final Assessment - The combination of deteriorating fundamentals, negative earnings revisions, and inclusion in a poorly performing industry group suggests that Molina Healthcare is unlikely to see significant recovery in the near term [13][14].

Core Viewpoint - Rosen Law Firm is urging investors of Molina Healthcare, Inc. to secure legal counsel before the December 2, 2025 deadline for a securities class action lawsuit related to undisclosed adverse facts affecting the company's financial guidance and operations [1][5]. Group 1: Class Action Details - The class action pertains to Molina securities purchased between February 5, 2025, and July 23, 2025, with a lead plaintiff deadline set for December 2, 2025 [1][2]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. Group 2: Allegations Against Molina - The lawsuit claims that Molina failed to disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [5]. - It is alleged that Molina's growth was reliant on limited utilization of various health services, which could lead to a significant cut in financial guidance for fiscal year 2025 [5]. - The lawsuit asserts that positive statements made by Molina regarding its business and prospects were materially misleading due to the undisclosed adverse facts [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and being ranked highly for securities class action settlements [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, highlighting the firm's expertise in this area [4].

Accessibility StatementSkip Navigation NEW YORK, Dec. 2, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline. So What: If you purchased Molina securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs thr ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. due to allegations of violations of federal securities laws, including making false or misleading statements regarding the company's financial health and medical cost trends [2][3]. Summary by Sections Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Molina Healthcare to contact them directly to discuss legal options [1]. - The firm has set a deadline of December 2, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against Molina [2]. Allegations Against Molina Healthcare - The complaint alleges that Molina and its executives failed to disclose material adverse facts about the company's medical cost trend assumptions and the dislocation between premium rates and medical costs [3]. - It is claimed that Molina's near-term growth relied on a lack of utilization of various health services, which led to a substantial likelihood of cutting financial guidance for fiscal year 2025 [3]. Financial Performance and Stock Impact - On July 7, 2025, Molina announced second-quarter financial results, revealing adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures [3]. - The company cut its full-year 2025 adjusted earnings per share guidance by 10.2%, from at least $24.50 to a range of $21.50 to $22.50 [3]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share on July 7, 2025 [3]. Further Financial Adjustments - On July 23, 2025, Molina further slashed its full-year 2025 earnings guidance, reporting a GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year over year [4]. - The new guidance for full-year 2025 adjusted earnings was set at no less than $19.00 per diluted share, representing a 13.6% cut from the previous guidance [4]. - Molina's stock price dropped by $32.03, or 16.84%, closing at $158.22 per share on July 24, 2025, following this announcement [4].

Core Viewpoint - Molina Healthcare, Inc. is facing a securities class action lawsuit due to alleged failures in disclosing material adverse facts regarding its financial health and operational assumptions during the class period from February 5, 2025, to July 23, 2025 [2][6]. Group 1: Class Action Details - The Rosen Law Firm is encouraging investors who purchased Molina securities during the specified class period to secure legal counsel before the December 2, 2025, lead plaintiff deadline [2][4]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by the deadline to represent other class members [4][8]. Group 2: Allegations Against Molina Healthcare - The lawsuit claims that Molina failed to disclose critical information, including adverse facts about its medical cost trend assumptions and the dislocation between premium rates and medical costs [6]. - It is alleged that Molina's near-term growth relied on a lack of utilization of various health services, which could lead to a significant cut in its financial guidance for fiscal year 2025 [6]. - The lawsuit asserts that the positive statements made by Molina regarding its business and prospects were materially misleading and lacked a reasonable basis [6]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [5]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [5]. - The firm emphasizes the importance of selecting qualified counsel with a proven success record in leading securities class actions [5].

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Molina investors who were adversely affected by alleged securities fraud between February 5, 2025 and July 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/molina-healthcare-inc-laws ...

MOH DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important December 2 Deadline in Securities Class Action - MOHNovember 29, 2025 10:21 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 29, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (t ...

Core Points - Class actions have been initiated on behalf of stockholders of Spirit Aviation Holdings, Inc. and Molina Healthcare, Inc. [1] Spirit Aviation Holdings, Inc. (OTCMKTS:FLYYQ) - The class period for the Spirit Aviation case is from May 28, 2025, to August 29, 2025, with a lead plaintiff deadline of December 1, 2025 [7] - Allegations include failure to disclose substantial risks regarding the company's ability to meet financial obligations and potential Chapter 11 bankruptcy [7] - Following the announcement of bankruptcy on August 29, 2025, Spirit's stock price fell by $0.71, or 58.2%, closing at $0.51 per share on September 3, 2025 [7] Molina Healthcare, Inc. (NYSE: MOH) - The class period for the Molina Healthcare case is from February 5, 2025, to July 23, 2025, with a lead plaintiff deadline of December 2, 2025 [7] - The complaint alleges that the company made materially false statements and failed to disclose adverse facts about its business operations and financial guidance for fiscal year 2025 [7] - Specific issues include misleading statements regarding medical cost trend assumptions and the dependency on a lack of utilization of various health services [7]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Molina Healthcare, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Molina Healthcare securities is from February 5, 2025, to July 23, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 2, 2025 [2]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions [3]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company [3]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions for investors [3]. Group 3: Case Allegations - The lawsuit alleges that Molina Healthcare failed to disclose several material adverse facts, including issues with medical cost trend assumptions and the impact on financial guidance for fiscal year 2025 [4]. - It is claimed that Molina's growth was dependent on a lack of utilization of various health services, which was not disclosed to investors [4]. - The lawsuit asserts that the positive statements made by Molina's management were materially misleading and lacked a reasonable basis [4].